-
Email -
Telephone
Mounjaro
Injection
- Once weekly injection
- Reduces appetite
- Up to 20% reduction in body weight
Price Checker
£134.99
Mounjaro Medical Information
Mounjaro is prescription medicine licensed for weight loss and weight maintenance in adults. Mounjaro primarily works by regulating your appetite, giving you a sense of satiety (‘fullness’), making you feel less hungry and experience less food cravings. This will help you eat less food and reduce your body weight.
Mounjaro is indicated for people with a BMI over 30 or a BMI over 27 with additional weight-related health concerns such as high blood pressure, diabetes, heart disease and raised cholesterol.
The dose should be started low (2.5mg) and then increased every 4 weeks until the required dose (5mg, 10mg or 15mg) is reached.
Mounjaro is given as an injection under the skin (subcutaneous injection). The best places to give the injection are the upper arms, stomach or upper legs.
Mounjaro is injected once a week on the same day each week, whenever possible. The injection can be administered at any time of the day – regardless of meals. If necessary, the day of the weekly injection of this medicine can be adjusted as long as it has been at least 3 days since the last injection.
Allergy to any of the ingredients in this medicine
Serious side effects
Uncommon (up to 1 in 100 people)
• Inflamed pancreas (acute pancreatitis) which could cause severe pain in the stomach and back which does not go away. You should see a doctor immediately if you experience such symptoms.
Rare (up to 1 in 1 000 people)
• Severe allergic reactions (e.g. anaphylactic reaction, angioedema). You should get immediate medical help and inform your doctor if you experience symptoms such as breathing problems, rapid swelling of the lips, tongue and/or throat with difficulty swallowing and a fast heartbeat.
Other side effects
Very common (more than 1 in 10 people)
• Low blood sugar (hypoglycaemia) when tirzepatide is used for the treatment of type 2 diabetes with medicines that contain a sulphonylurea and/or insulin. If you are using a sulphonylurea or insulin, the dose may need to be lowered while you use tirzepatide. Symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating. Your doctor should tell you how to treat low blood sugar.
• Feeling sick (nausea)
• Diarrhoea
• Being sick (vomiting) – this usually goes away over time
• Constipation
Common (up to 1 in 10 people)
• Low blood sugar (hypoglycaemia) when tirzepatide is used for type 2 diabetes with both metformin and a sodium-glucose co-transporter 2 inhibitor (another diabetes medicine). Symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating. Your doctor should tell you how to treat low blood sugar.
• Allergic reaction (hypersensitivity) (e.g., rash, itching, and eczema)
• Dizziness observed in patients treated for weight management
• Low blood pressure observed in patients treated for weight management
• Feeling less hungry (decreased appetite) observed in patients treated for type 2 diabetes
• Stomach (abdominal) pain - Indigestion (dyspepsia)
• Bloating of the stomach -
•Burping (eructation)
• Gas (flatulence)
• Reflux or heartburn (also called gastroesophageal reflux disease – GORD) - a disease caused by stomach acid coming up into the tube from your stomach to your mouth
• Hair loss observed in patients treated for weight management
• Feeling tired (fatigue) - Injection site reactions (e.g. itching or redness)
• Fast pulse
• Increased levels of pancreatic enzymes (such as lipase and amylase2 ) in blood.
Uncommon (up to 1 in 100 people)
• Low blood sugar (hypoglycaemia) when tirzepatide is used with metformin for type 2 diabetes. Symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating. Your doctor should tell you how to treat low blood sugar.
• Gallstones - Weight loss observed in patients treated for type 2 diabetes
• Injection site pain
• Increased calcitonin levels in blood
• Cholecystitis (infection of the gallbladder) observed in patients treated for weight management.
Wegovy Injection
- Once weekly injection
- Appetite suppressant
